News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Aug 25, 2021 COVID-19 Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems Download Aug 16, 2021 Corporate and finance Novavax Appoints Biopharmaceutical Veterans Jim Kelly as Chief Financial Officer and Nasir Egal, Ph.D., as Senior Vice President of Quality Assurance Download Aug 5, 2021 Novavax Reports Second Quarter 2021 Financial Results and Operational Highlights Download Aug 5, 2021 COVID-19 Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination Download Aug 5, 2021 COVID-19 Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine Download Aug 4, 2021 COVID-19 Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine Download Jul 6, 2021 Corporate and finance Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021 Download Jun 30, 2021 COVID-19 Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine Download Jun 30, 2021 StatementCOVID-19 Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants: Updated June 30, 2021 Download Jun 22, 2021 StatementCOVID-19 Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre Download Jun 17, 2021 Corporate and finance Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum Download Jun 17, 2021 Corporate and finance Novavax to Participate in National Vaccine Advisory Committee Meeting Download Jun 14, 2021 COVID-19Seasonal influenza Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously Download Jun 14, 2021 COVID-19 Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial Download Jun 11, 2021 COVID-19 Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine Download Jun 9, 2021 Corporate and finance Novavax to Host Maryland Governor Larry Hogan at Site of Future Novavax Vaccines Innovation Campus and Global Headquarters Download Jun 7, 2021 COVID-19 Novavax to Participate in Panel at BIO Digital 2021 Download May 27, 2021 COVID-19 Novavax to Participate in Jefferies Virtual Healthcare Conference Download May 24, 2021 COVID-19 Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update Download May 22, 2021 COVID-19 Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea Download May 22, 2021 StatementCOVID-19 Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants in the United Kingdom Download May 21, 2021 StatementCOVID-19 Complete Trial Results Manuscript of Novavax COVID-19 Investigational Vaccine Posted to Preprint Server medRxiv Download May 21, 2021 StatementCOVID-19 Novavax Statement on Participation in Mix-and-Match COVID-19 Vaccine Booster Trial in the United Kingdom Download May 21, 2021 Corporate and finance Novavax Honored by Maryland Tech Council During 2021 Industry Awards Celebration Download May 10, 2021 Corporate and finance Novavax Reports First Quarter 2021 Financial Results and Operational Highlights Download May 10, 2021 StatementCOVID-19 Novavax Statement on Updated PREVENT-19 Trial Protocol Download May 10, 2021 COVID-19Seasonal influenza Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate Download May 7, 2021 StatementCOVID-19 Novavax Statement on Ministry of Health, Labour and Welfare’s Announcement Regarding Procurement from Takeda of NVX-CoV2373 for Japan Download May 7, 2021 StatementCOVID-19 Novavax Statement in Opposition to the WTO TRIPS Waiver Download May 6, 2021 COVID-19 Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility Download May 5, 2021 New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant Download May 3, 2021 Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine Download Apr 23, 2021 Novavax to Host Conference Call to Discuss First Quarter Financial Results and Operational Highlights on May 10, 2021 Download Apr 23, 2021 Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet Download Apr 14, 2021 COVID-19 Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations Download Apr 13, 2021 Corporate and finance Novavax Announces Leadership Updates Download Apr 8, 2021 Corporate and finance Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference Download Apr 5, 2021 Corporate and finance Novavax CEO Stan Erck to Participate in Longwood Healthcare Leaders Meeting Download Apr 5, 2021 COVID-19 Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover Download Mar 29, 2021 COVID-19 GSK to support manufacture of Novavax' COVID-19 vaccine Download Mar 11, 2021 COVID-19 Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials Download Mar 8, 2021 Corporate and finance Novavax to Participate in H.C. Wainwright Virtual Global Life Sciences Conference Fireside Chat Download Mar 1, 2021 Corporate and finance Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights Download Feb 26, 2021 COVID-19 Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan Download Feb 22, 2021 COVID-19 Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico Download Feb 18, 2021 COVID-19 Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine Download Feb 16, 2021 Corporate and finance Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021 Download Feb 15, 2021 COVID-19 Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea Download Feb 4, 2021 COVID-19 Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization Download Feb 3, 2021 COVID-19 Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine Download Show 5102550100 per page«12345678»